✦ LIBER ✦

371 ANALGESIC EFFICACY OF CELECOXIB AND DICLOFENAC IN PATIENTS WITH OSTEOARTHRITIS REQUIRING HIP REPLACEMENT SURGERY

✍ Scribed by P. Emery; T. Koncz; M. Small; S. Lowry

Book ID: 108487229
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 52 KB
Volume: 10
Category: Article
ISSN: 1090-3801
DOI: 10.1016/s1090-3801(06)60374-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analgesic effectiveness of celecoxib and

Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study

✍ Paul Emery; Tamas Koncz; Sharon Pan; Simon Lowry 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Perceptions of Physician Recommendations

Perceptions of Physician Recommendations for Joint Replacement Surgery in Older Patients with Severe Hip or Knee Osteoarthritis

✍ Mara A. Schonberg; Edward R. Marcantonio; Mary Beth Hamel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Cutpoints for mild, moderate and severe

Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery

✍ Heidi Kapstad; Berit R Hanestad; Norvald Langeland; Tone Rustøen; Knut Stavem 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 296 KB

Feasibility and efficacy of an 8-week pr

Feasibility and efficacy of an 8-week progressive home-based strengthening exercise program in patients with osteoarthritis of the hip and/or total hip joint replacement: a preliminary trial

✍ Benjamin Steinhilber; Georg Haupt; Regina Miller; Johannes Boeer; Stefan Grau; P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 179 KB

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m